If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Long Term Incentive Plan

16 Jun 2008 08:34

RNS Number : 7610W
PureCircle Limited
16 June 2008
 



PURECIRCLE LIMITED

(PureCircle or The Company)

LONG TERM INCENTIVE PLAN

16 June 2008

The Board of PureCircle have approved the establishment of a Long Term Incentive Plan which it is envisaged will involve the issue of options or conditional awards over shares in PureCircle to key employees including Executive Directors. The non executive directors consider such a plan appropriate in order to recruit, retain and motivate key employees on a basis aligned fully with shareholders.

In drafting the Plan, Pure Circle has sought to implement a plan commensurate with the Company's positioning as an AIM listed high growth multi-national business. In setting up the Plan, the Company was advised by Hewitt New Bridge Street, the leading UK Remuneration Consultants.

The principal terms of the Plan include:

a restriction on the Company issuing (or granting rights to issue) more than 10 per cent of its issued ordinary share capital under the Plan (and any other employee share plan) in any ten calendar year period

awards may be linked to performance conditions. It is currently intended that, other than in exceptional circumstances, such asenior recruitment, all awards will be subject to performance conditions and that, initially, the performance conditions will be linked principally to Company share price. However, in the future the Plan also allows for internal target measures to be used where such measures are themselves drivers of shareholder value

The Plan recognises the fast growth and changing nature of the Company and the need to recruit and retain executives in very different employment markets around the world. Accordingly the Plan allows for the Remuneration Committee to exercise significant discretion in exceptional cases where the Committee considers executives will bring particular value to shareholders. 

WILLIAM MITCHELL - GROUP FINANCE DIRECTOR

Further to the announcement of the appointment of William Mitchell as Group Finance Director of 2 June 2008, PureCircle announces that the Remuneration Committee has approved the issue to Mr Mitchell of 600,000 options over shares in PureCircle, with each option being exercisable at a strike price of US$1.00 ("The Joining Options"). The Joining Options will be satisfied by the transfer of existing treasury shares and by the issue of up to 480,000 new shares in the Company to Mr. Mitchell. Subject to the options vesting as detailed below, the Joining Options are exercisable by Mr. Mitchell at any time up to and including 12 June 2015.

The Joining Options vest as follows.

1. 120,000 Joining Options immediately;

2. 120,000 Joining Options on 1 November 2008 (with no conditions precedent other than that Mr Mitchell remains in the employment of the Company at 1 November 2008);

3. 180,000 Joining Options on the later of 12 June 2009 or a date subsequent, subject to the average closing price of PureCircle shares being at least £2.00 over 20 consecutive days (provided that period occurs before 12 June 2013); and

4. 180,000 Joining Options on the later of 12 June 2009 or a date subsequent, subject to the average closing price of PureCircle shares being at least £2.50 over 20 consecutive days (provided that period occurs before 12 June 2013)

In the event there is a change of control the conditions precedent to the vesting of the Joining Options will lapse and the Joining Options may be exercised in full.

Mr Mitchell has exercised the 120,000 Joining Options which have vested immediately on grant

The issue of the Joining Options to Mr Mitchell is part of his remuneration package and is intended to align his remuneration closely to the success of PureCircle in a way similar to the other executive directors of the Company who each held shares in PureCircle prior to its Admission to AIM.

The Board has also approved the issue to Mr Mitchell of a conditional award of up to 290,055 shares ("The 2008 conditional award"). The 2008 conditional award vests as follows:

1. Up to 96,685 shares on the later of 12 June 2009 or a date subsequent, subject to the average closing price of PureCircle shares being at least £4.00 over 20 consecutive days (provided that period occurs before 12 June 2011)

2. Up to 193,370 shares on 12 June 2011subject to the average closing price of PureCircle shares having been at least £4.00 over 20 consecutive days before 12 June 2011

The 2008 conditional award is subject to a sliding scale performance condition dependent upon the average closing price of PureCircle shares. 

1. Below £2.50: no part of the 2008 conditional award vests

2. At £2.50: 30% vests

3. At £4.00: 100% vests

4. Between £2.50 and £4.00 vesting is prorated on a straight line basis

There is no exercise price for the 2008 conditional award.

The terms of both the Joining Options and the 2008 conditional award also entitle Mr Mitchell to receive a benefit in cash and/or shares determined by reference to the value of the dividends paid on shares in respect of dividend record dates occurring between the 12 June 2008 and the relevant vesting date.

Enquiries:

College Hill

Tel: +44 20 7457 2020

Mark Garraway

RFC Corporate Finance Ltd

Tel: +61 9 480 2500

Stephen Allen

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFKAKNOBKKNAD
Date   Source Headline
8th Jul 20137:30 amRNSOptions Granted To and Exercised by Directors
2nd Jul 20137:00 amRNSPRE CLOSE PERIOD UPDATE 2H FY 2013
1st Jul 20137:00 amRNSDiscovery and Development of new Food Ingredient
24th May 20137:34 amRNSDealings in Shares
17th May 201311:43 amRNSTransfer of Shares
26th Apr 20138:47 amRNSDirector/PDMR Shareholding
24th Apr 20138:23 amRNSDealings in Shares
22nd Apr 20138:02 amRNSDealings in Shares
11th Apr 201311:08 amRNSDealings in Shares
25th Mar 20137:48 amRNSDealings in Shares
22nd Mar 20138:19 amRNSDealings in Shares
21st Mar 20139:41 amRNSDealings in Shares
20th Mar 20138:25 amRNSIssue of Equity
19th Mar 20138:26 amRNSDealings in Shares
13th Mar 20139:45 amRNSDirector/PDMR Shareholding
13th Mar 20137:00 amRNSInterim Results
7th Mar 20138:30 amRNSAnnouncement of Interim Results and Investor Call
4th Mar 20137:00 amRNSMajor New Product Commercialisation
7th Jan 20137:00 amRNSTrading Update
31st Dec 201210:14 amRNSNotification of a Major Interest
28th Dec 20127:00 amRNSBoard Change
27th Dec 20129:10 amRNSDirector/PDMR Shareholding
12th Dec 201211:25 amRNSResult of AGM
12th Dec 20129:55 amRNSHolding(s) in Company
5th Dec 20128:19 amRNSDirector/PDMR Shareholding
3rd Dec 20128:00 amRNSCanadian Regulatory Approval for Stevia
26th Nov 20128:57 amRNSDirector/PDMR Shareholding
23rd Nov 20128:32 amRNSHolding(s) in Company
22nd Nov 20128:34 amRNSHolding(s) in Company
21st Nov 201211:39 amRNSDealings in Shares
21st Nov 20129:54 amRNSDealings in Shares
20th Nov 20128:31 amRNSDealings in Shares
16th Nov 20127:00 amRNSNotice of AGM and Annual Report
14th Nov 20128:31 amRNSHolding(s) in Company
13th Nov 20128:55 amRNSNotification of a Major Interest
12th Nov 20128:48 amRNSDirector/PDMR Shareholding
8th Nov 20128:30 amRNSNotification of a Major Interest
2nd Nov 201210:12 amRNSDirector/PDMR Shareholding
2nd Nov 20129:03 amRNSDirector/PDMR Shareholding
1st Nov 20128:55 amRNSDirector/PDMR Shareholding
29th Oct 20129:01 amRNSExercise of Options
24th Oct 20128:26 amRNSDirector/PDMR Shareholding
22nd Oct 20128:23 amRNSDirector/PDMR Shareholding
18th Oct 20129:10 amRNSDirector/PDMR Shareholding
16th Oct 201211:16 amRNSHolding(s) in Company
12th Oct 20127:14 amRNSDirector/PDMR Shareholding
11th Oct 20127:11 amRNSDirector/PDMR Shareholding
10th Oct 20127:26 amRNSDirector/PDMR Shareholding
9th Oct 20127:57 amRNSDirector/PDMR Shareholding
5th Oct 20128:21 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.